Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae : A proof of principle study ISRCTN48328635 ISRCTN
Objective: Infections with multidrug-resistant microorganisms are associated with increased hospitalization, medication costs and mortality. Based on our fecal microbiota transplantation (FMT) experience for Clostridium difficile infection, we treated 15 patients carrying ESBL-producing Enterobacteriaceae (ESBL-EB) with FMT. Seven patients underwent a second FMT after 4 weeks when ESBL-EB remained, amounting to a total number of 22 transplants. The objective was decolonization of ESBL-EB. Results: Three out of fifteen (20%) patients were ESBL-negative at 1, 2 and 4 weeks after the first transplant, while six out of 15 (40%) were negative after the second transplant. Comparison of fecal microbiota at baseline and 4 weeks after FMT revealed restoration of microbial diversity after FMT and a microbial shift towards donor composition. Finally, we suggest several possible factors of response to therapy, such as donor-recipient microbiota match and number of FMTs. Therefore, FMT can be an effective treatment in patients carrying ESBL-EB. Response may be determined by microbiota composition and number of FMT procedures. Trial registration ISRCTN ISRCTN48328635 Registered 11 October 2017, retrospectively registered.
Main Authors: | , , , , , , , , |
---|---|
Format: | Article/Letter to editor biblioteca |
Language: | English |
Subjects: | ESBL, Fecal microbiota transplantation, Microbiota, Multidrug resistance microorganisms, |
Online Access: | https://research.wur.nl/en/publications/fecal-microbiota-transplantation-against-intestinal-colonization- |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
dig-wur-nl-wurpubs-536122 |
---|---|
record_format |
koha |
spelling |
dig-wur-nl-wurpubs-5361222024-10-02 Singh, Ramandeep de Groot, Pieter F. Geerlings, Suzanne E. Hodiamont, Caspar J. Belzer, Clara ten Berge, Ineke J.M. de Vos, Willem M. Bemelman, Frederike J. Nieuwdorp, Max Article/Letter to editor BMC Research Notes 11 (2018) 1 ISSN: 1756-0500 Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae : A proof of principle study ISRCTN48328635 ISRCTN 2018 Objective: Infections with multidrug-resistant microorganisms are associated with increased hospitalization, medication costs and mortality. Based on our fecal microbiota transplantation (FMT) experience for Clostridium difficile infection, we treated 15 patients carrying ESBL-producing Enterobacteriaceae (ESBL-EB) with FMT. Seven patients underwent a second FMT after 4 weeks when ESBL-EB remained, amounting to a total number of 22 transplants. The objective was decolonization of ESBL-EB. Results: Three out of fifteen (20%) patients were ESBL-negative at 1, 2 and 4 weeks after the first transplant, while six out of 15 (40%) were negative after the second transplant. Comparison of fecal microbiota at baseline and 4 weeks after FMT revealed restoration of microbial diversity after FMT and a microbial shift towards donor composition. Finally, we suggest several possible factors of response to therapy, such as donor-recipient microbiota match and number of FMTs. Therefore, FMT can be an effective treatment in patients carrying ESBL-EB. Response may be determined by microbiota composition and number of FMT procedures. Trial registration ISRCTN ISRCTN48328635 Registered 11 October 2017, retrospectively registered. en application/pdf https://research.wur.nl/en/publications/fecal-microbiota-transplantation-against-intestinal-colonization- 10.1186/s13104-018-3293-x https://edepot.wur.nl/445787 ESBL Fecal microbiota transplantation Microbiota Multidrug resistance microorganisms https://creativecommons.org/licenses/by/4.0/ Wageningen University & Research |
institution |
WUR NL |
collection |
DSpace |
country |
Países bajos |
countrycode |
NL |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-wur-nl |
tag |
biblioteca |
region |
Europa del Oeste |
libraryname |
WUR Library Netherlands |
language |
English |
topic |
ESBL Fecal microbiota transplantation Microbiota Multidrug resistance microorganisms ESBL Fecal microbiota transplantation Microbiota Multidrug resistance microorganisms |
spellingShingle |
ESBL Fecal microbiota transplantation Microbiota Multidrug resistance microorganisms ESBL Fecal microbiota transplantation Microbiota Multidrug resistance microorganisms Singh, Ramandeep de Groot, Pieter F. Geerlings, Suzanne E. Hodiamont, Caspar J. Belzer, Clara ten Berge, Ineke J.M. de Vos, Willem M. Bemelman, Frederike J. Nieuwdorp, Max Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae : A proof of principle study ISRCTN48328635 ISRCTN |
description |
Objective: Infections with multidrug-resistant microorganisms are associated with increased hospitalization, medication costs and mortality. Based on our fecal microbiota transplantation (FMT) experience for Clostridium difficile infection, we treated 15 patients carrying ESBL-producing Enterobacteriaceae (ESBL-EB) with FMT. Seven patients underwent a second FMT after 4 weeks when ESBL-EB remained, amounting to a total number of 22 transplants. The objective was decolonization of ESBL-EB. Results: Three out of fifteen (20%) patients were ESBL-negative at 1, 2 and 4 weeks after the first transplant, while six out of 15 (40%) were negative after the second transplant. Comparison of fecal microbiota at baseline and 4 weeks after FMT revealed restoration of microbial diversity after FMT and a microbial shift towards donor composition. Finally, we suggest several possible factors of response to therapy, such as donor-recipient microbiota match and number of FMTs. Therefore, FMT can be an effective treatment in patients carrying ESBL-EB. Response may be determined by microbiota composition and number of FMT procedures. Trial registration ISRCTN ISRCTN48328635 Registered 11 October 2017, retrospectively registered. |
format |
Article/Letter to editor |
topic_facet |
ESBL Fecal microbiota transplantation Microbiota Multidrug resistance microorganisms |
author |
Singh, Ramandeep de Groot, Pieter F. Geerlings, Suzanne E. Hodiamont, Caspar J. Belzer, Clara ten Berge, Ineke J.M. de Vos, Willem M. Bemelman, Frederike J. Nieuwdorp, Max |
author_facet |
Singh, Ramandeep de Groot, Pieter F. Geerlings, Suzanne E. Hodiamont, Caspar J. Belzer, Clara ten Berge, Ineke J.M. de Vos, Willem M. Bemelman, Frederike J. Nieuwdorp, Max |
author_sort |
Singh, Ramandeep |
title |
Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae : A proof of principle study ISRCTN48328635 ISRCTN |
title_short |
Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae : A proof of principle study ISRCTN48328635 ISRCTN |
title_full |
Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae : A proof of principle study ISRCTN48328635 ISRCTN |
title_fullStr |
Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae : A proof of principle study ISRCTN48328635 ISRCTN |
title_full_unstemmed |
Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae : A proof of principle study ISRCTN48328635 ISRCTN |
title_sort |
fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing enterobacteriaceae : a proof of principle study isrctn48328635 isrctn |
url |
https://research.wur.nl/en/publications/fecal-microbiota-transplantation-against-intestinal-colonization- |
work_keys_str_mv |
AT singhramandeep fecalmicrobiotatransplantationagainstintestinalcolonizationbyextendedspectrumbetalactamaseproducingenterobacteriaceaeaproofofprinciplestudyisrctn48328635isrctn AT degrootpieterf fecalmicrobiotatransplantationagainstintestinalcolonizationbyextendedspectrumbetalactamaseproducingenterobacteriaceaeaproofofprinciplestudyisrctn48328635isrctn AT geerlingssuzannee fecalmicrobiotatransplantationagainstintestinalcolonizationbyextendedspectrumbetalactamaseproducingenterobacteriaceaeaproofofprinciplestudyisrctn48328635isrctn AT hodiamontcasparj fecalmicrobiotatransplantationagainstintestinalcolonizationbyextendedspectrumbetalactamaseproducingenterobacteriaceaeaproofofprinciplestudyisrctn48328635isrctn AT belzerclara fecalmicrobiotatransplantationagainstintestinalcolonizationbyextendedspectrumbetalactamaseproducingenterobacteriaceaeaproofofprinciplestudyisrctn48328635isrctn AT tenbergeinekejm fecalmicrobiotatransplantationagainstintestinalcolonizationbyextendedspectrumbetalactamaseproducingenterobacteriaceaeaproofofprinciplestudyisrctn48328635isrctn AT devoswillemm fecalmicrobiotatransplantationagainstintestinalcolonizationbyextendedspectrumbetalactamaseproducingenterobacteriaceaeaproofofprinciplestudyisrctn48328635isrctn AT bemelmanfrederikej fecalmicrobiotatransplantationagainstintestinalcolonizationbyextendedspectrumbetalactamaseproducingenterobacteriaceaeaproofofprinciplestudyisrctn48328635isrctn AT nieuwdorpmax fecalmicrobiotatransplantationagainstintestinalcolonizationbyextendedspectrumbetalactamaseproducingenterobacteriaceaeaproofofprinciplestudyisrctn48328635isrctn |
_version_ |
1813440481085882368 |